Bovine dialyzable leukocyte extract modulates the nitric oxide and proinflammatory cytokine production in lipopolysaccharide-stimulated murine peritoneal macrophages in vitro

Journal of Medicinal Food

Volumn 8, Issue 1, 2005, Pages 20-26

  Franco Molina, Moisés Armides ^a,b   Mendoza Gamboa, Edgar ^a   Castillo León, Leonardo ^a   Tamez Guerra, Reyes S ^a   Rodríguez Padilla, Cristina ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b Cd Universitaria ^*  (Mexico)

Author keywords

Bovine dialyzable leukocyte extract; Cytokines; Endotoxic shock; Lipopolysaccharide

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BOVINE DIALYZABLE LEUKOCYTE EXTRACT; INTERLEUKIN 10; INTERLEUKIN 6; LEUKOCYTE EXTRACT; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; CATTLE; CELL EXTRACTS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; SHOCK, SEPTIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; MURINAE; NEGIBACTERIA;

EID: 18144427475     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.8.20     Document Type: Article

References (25)

1. Yoshikawa T, Takano H, Takashi S, Ichikawa H, Kondo M: Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ Shock 1994;42:53-58.
2. Fretland CH, Widomski DL, Thompson JM: Non-lethal sepsis and nitric oxide inhibition in the guinea pig. Inflammation 2000;24:219-225.
3. Xaus J, Comalada M, Valledor AF, et al.: LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-α. Blood 2000;95:3823-3831.
4. Victor VM, De la Fuente M: Comparative study of peritoneal macrophage functions in mice receiving lethal and non-lethal doses of LPS. J Endotoxin Res 2000;6:1125-1136.
5. Moore JK, Andersson LP, Ingalls RR, et al.: Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 2000;165:4272-4280.
6. Amura CR, Amura R, Silverstein R, Morrison DC: Mechanism involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun 1988;3:5372-5378.
7. Chaby R: Strategies for the control of LPS-mediated pathophysiological disorders. Drug Discov Today 1999;4:209-221.
8. Estrada PS, Nagaya A, Serrano E, et al.: Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int J Immunopharmacol 1998;20:521-535.
9. Gottlieb AA, Maziarz GA, Tamaki N, Sutcliffe SB: The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response. J Immunol 1980;124:1123-1131.
10. Ojeda OM, Fernandez CB, Rosaínz MJ: Dialyzable leukocyte extract (DLE) reduces lipopolysaccharide-induced tumor necrosis factor secretion in human leukocytes. Biotherapy 1996;9:163-170.
11. Gomez FR, Rodriguez PC, Metha RT, Wong LG, Mendoza GE, Tamez GR: Nitric oxide and TNF-α production by murine peritoneal macrophages activated with a novel 20-kDa protein isolated from Bacillus thuringiensis var. thuringiensis parasporal bodies. J Immunol 1997;158:3796-3799.
12. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141;2407-2412.
13. Haddad KE, Duclos JA, Antecka E, Lapp SW, Baines GM: Role of interferon-γ in the priming of decidual macrophages for nitric oxide production and early pregnancy loss. Cell Immunol 1997;181:68-75.
14. West AM, Baker J, Bellingham J, Calir L: Discordant reprogramming of LPS-stimulated cytokine gene transcription and secretion by macrophages after LPS pretreatment. J Surg Res 1996;63:209-214.
15. Szabo C: Alterations in the production of nitric oxide in various forms of circulatory shock. New Horizons 1995;3:3-32.
16. Gallay P, Jongeneel CV, Barras C, et al.: Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J Immunol 1993;150:5086-5093.
17. Knopf HP, Otto F, Engelhardt R, et al.: Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953: Down-regulation of TNF-alpha and 1L-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression. J Immunol 1994;153:287-299.
18. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431.
19. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
20. Jessica CA, Steege T, De Yen MW, Forget P, Brouckaert P, Buurman WA: The role of endogenous INFγ, TNF-α, IL-10 in LPS-induced nitric oxide release in a mouse model. Cytokine 1998;10:115-123.
21. Natanson CP, Eichenholz W, Danner RL, et al.: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-830.
22. Hogaboam CM, Steinhauser ML, Harold SN, Strieter RM, Standiford T, Kunkel SL: Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: Role of interleukin-10 and monocyte chemo attractant protein. Infect Immun 1998;66:650-655.
23. Jones AS, Horiuchi S, Topley N, Yamamoto N, Fuller MG: The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 2001;15:43-58.
24. Xing Z, Gauldie J, Cox G, et al.: IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.
25. Stuehr DJ: Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 1997;37:339-359.